Risk factors for and characteristics of pneumonitis in patients treated with anti-programmed death-1 therapy. This is an ASCO Meeting Abstract from the 2018 ASCO-SITC Clinical Immuno-Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results